All News

Legendary Van Halen lead guitarist, Eddie Van Halen, died on Tuesday from cancer. He was 65.

Cancer survivor offers his advice to the newly diagnosed as they start their treatment journey.

In a clinical trial, adding the CDK4/6 inhibitor Ibrance (palbociclib) to the hormonal treatment Faslodex (fulvestrant) delayed disease progression in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.

Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.

Dry mouth is a common cancer treatment-related side effect for patients, but a new experimental therapy could help with that.

Overall survival was better with hepatic arterial infusion chemotherapy compared with transarterial chemoembolization, according to phase 3 study findings.

On social media, CURE® recently asked its readers to share the most important lesson cancer taught them.

CLL patient shares his experience with the disease and the importance of aiming to live his life to the fullest despite his diagnosis.

For head and neck cancer survivor Jason Mendelsohn surviving cancer was only the beginning of his journey as handling severe side effects from treatment altered his day-to-day life.

“The combination of cabozantinib (Cabometyx) and atezolizumab (Tecentriq) demonstrated encouraging clinical activity in previously untreated patients with advanced ccRCC,” Dr. Sumanta Kumar Pal, co-director of the Kidney Cancer Program at City of Hope in California, said during a presentation of the clear cell renal cell carcinoma cohort.

A patient with multiple myeloma shares his story and how his oncology nurse has provided him with care and empathy on his cancer journey.

A cancer survivor explains why those of us who face cancer and now COVID-19 feel the way we do when confronting an ongoing crisis.

Finding balance to detect and treat prostate cancer without overtreatment is important for patients.

Self-reliance can be a challenge after a long cancer journey but taking on even small steps can make a major difference in moving forward.

PARP inhibitors are not only expanding the field of prostate cancer but they're giving men another option for life after cancer.

In this essay, a nurse colleague shows how extraordinary healer Deborah Austin Thompson is both an exceptional comforter and healer for patients with cancer.

The Food and Drug Administration’s approval of Opdivo in combination with Yervoy for patients with unresectable malignant pleural mesothelioma marks the first new systemic therapy approved in more than 15 years in this setting.

After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.

Chemotherapy sessions are not just physically taxing for patients with cancer, but they’re also mentally draining. Here are five ways one cancer survivor decompressed after chemotherapy sessions.

From study results demonstrating that the HPV vaccine substantially reduces the risk of cervical cancer to the first person known to be cured of HIV dying from acute myeloid leukemia, here’s what’s happening in the cancer landscape this week.

New treatments are needed for penile cancer, but it’s difficult to test drugs in clinical trials because the disease is so uncommon.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for September 2020.

Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.

When going through cancer, you are often waiting for more bad news to come because it comes far more often than good news does. It is hard to let your guard down and recognize that while that was life during cancer, that is not your life anymore.

For some patients with metastatic kidney cancer, undergoing surgery after targeted or immune therapy sparks better health outcomes.

Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.

Cancer, unfortunately, forces you to adapt or be miserable. There’s a solution to the side effects of treatment out there. You just have to find it.

After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.

VERU Inc. announced it has completed enrollment of 40 men with metastatic prostate cancer who have become resistant to at least one androgen receptor targeting agent for its phase 2 study of VERU-111.

A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.